Understanding the menopause transition involves addressing common misconceptions, particularly about hormone replacement therapy (HRT). Dr. Polly Watson addresses the enduring myth that associates all forms of HRT with breast cancer, tracing its origins to a misinterpretation of the Women's Health Initiative study. She clarifies the distinction between bioidentical progesterone and synthetic progestogens, highlighting their differing effects on breast cancer risk. Furthermore, she emphasizes the significance of personalized HRT protocols.

Dispelling the belief that HRT's sole purpose is to combat hot flashes, Dr. Polly delves into its FDA-approved benefits and beyond. These include easing joint pain, improving mood, supporting cardiovascular health, and preventing osteoporosis. She also addresses the crucial, yet often overlooked, aspect of vaginal health in menopausal well-being.

This episode goes further to clarify that not all HRT is created equal, distinguishing between the forms of estrogen administration and their associated risks, and debunking the common fear that HRT invariably leads to weight gain. Dr. Polly explains that menopause itself, not HRT, often triggers changes in the body that can affect weight.

Moreover, Dr. Polly explores the world of FDA-approved bioidentical hormones, debunking the myth that only compounded hormones fit this category. She offers a reality check on testosterone's role in libido and introduces promising non-hormonal treatments for those unable to use HRT due to medical reasons.

Dr. Polly encourages listeners to approach menopause armed with facts and to seek customized care from their healthcare providers.

Quotes

• “If we're talking about hormone replacement therapy and breast cancer risk, the type of progesterone or progestogen really matters in relation to that risk.” (05:58 | Dr. Polly Watson)
• “We live in a really polluted world. There are lots of complicated facts, family history, lifestyle, alcohol use, body mass index, breast density, all of those things come into breast cancer risk. So we can never guarantee anyone, there's no risk of breast cancer, but we can make more insightful choices when we're offering hormone replacement therapy.” (06:26 | Dr. Polly Watson)
• “It's important to understand that hormone replacement therapy is FDA approved only for four things: hot flashes, night sweats, urogenital symptoms like vaginal dryness, sexual pain, and the prevention of osteoporosis. So we know that giving estrogen, particularly earlier in the menopause transition, can delay bone loss.” (07:21 | Dr. Polly Watson)
• “I think where I see the greatest positive health change is if we can get people to sleep, if you can treat their vasomotor symptoms and get them to be able to sleep, then they have the bandwidth to do all the work they need to lift weights, eat more protein, build more lean muscle mass, glycemically balanced nutritional load, et cetera. ” (15:05 | Dr. Polly Watson)
• “Women need a very clear and honest conversation about sexual health and libido.” (22:23 | Dr. Polly Watson)

Links

https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf

Links

Connect with Dr. Polly Watson:

Website: https://hormonewellnessmd.com/podcast

Resources: https://hormonewellnessmd.com/podcast-resources

Disclaimer: https://hormonewellnessmd.com/podcast#Disclaimer

Podcast production and show notes provided by HiveCast.fm